These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

839 related items for PubMed ID: 8971083

  • 1. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study.
    Haffner SM, Howard G, Mayer E, Bergman RN, Savage PJ, Rewers M, Mykkänen L, Karter AJ, Hamman R, Saad MF.
    Diabetes; 1997 Jan; 46(1):63-9. PubMed ID: 8971083
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
    Howard BV, Mayer-Davis EJ, Goff D, Zaccaro DJ, Laws A, Robbins DC, Saad MF, Selby J, Hamman RF, Krauss RM, Haffner SM.
    Metabolism; 1998 Oct; 47(10):1174-9. PubMed ID: 9781617
    [Abstract] [Full Text] [Related]

  • 6. Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic whites with a parental history of diabetes.
    Haffner SM, Miettinen H, Stern MP.
    J Clin Endocrinol Metab; 1996 May; 81(5):1846-51. PubMed ID: 8626845
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nondiabetic Mexican-Americans do not have reduced insulin responses relative to nondiabetic non-Hispanic whites.
    Haffner SM, Miettinen H, Stern MP.
    Diabetes Care; 1996 Jan; 19(1):67-9. PubMed ID: 8720538
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Higher insulin and C-peptide concentrations in Hispanic population at high risk for NIDDM. San Luis Valley Diabetes Study.
    Boyko EJ, Keane EM, Marshall JA, Hamman RF.
    Diabetes; 1991 Apr; 40(4):509-15. PubMed ID: 2010052
    [Abstract] [Full Text] [Related]

  • 11. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.
    Osei K, Gaillard T, Schuster DP.
    Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394
    [Abstract] [Full Text] [Related]

  • 12. Insulin action in black Americans with NIDDM.
    Banerji MA, Lebovitz HE.
    Diabetes Care; 1992 Oct; 15(10):1295-302. PubMed ID: 1425092
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study.
    Hamman RF, Mayer EJ, Moo-Young GA, Hildebrandt W, Marshall JA, Baxter J.
    Diabetes; 1989 Oct; 38(10):1231-7. PubMed ID: 2792575
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
    Festa A, D'Agostino R, Rich SS, Jenny NS, Tracy RP, Haffner SM.
    Circulation; 2003 May 20; 107(19):2422-7. PubMed ID: 12719278
    [Abstract] [Full Text] [Related]

  • 19. Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans.
    Palmer ND, Lehtinen AB, Langefeld CD, Campbell JK, Haffner SM, Norris JM, Bergman RN, Goodarzi MO, Rotter JI, Bowden DW.
    J Clin Endocrinol Metab; 2008 Jan 20; 93(1):304-9. PubMed ID: 17971425
    [Abstract] [Full Text] [Related]

  • 20. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention.
    Osei K, Rhinesmith S, Gaillard T, Schuster D.
    Diabetes Care; 2004 Jun 20; 27(6):1439-46. PubMed ID: 15161801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.